Biodegradable targeted polymeric mRNA nanoparticles enable in vivo CD19 CAR T cell generation and lead to B cell depletion
Science Advances · 2026
DOI: 10.1126/sciadv.adz1722 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Manav Jain und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. Hauptthemen laut MEDLINE: Nanoparticles, Antigens, CD19, B-Lymphocytes, RNA, Messenger. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
While chimeric antigen receptor (CAR) T cell therapies have demonstrated therapeutic efficacy against B cell malignancies, widespread implementation of these therapies is hindered by a cumbersome, ex vivo manufacturing process. Delivery of CAR-encoding messenger RNA (mRNA) to endogenous T cells can generate these therapeutic cells in vivo and streamline this manufacturing workflow. To accomplish this, T cell–activating ligands were conjugated to a biodegradable polymeric mRNA nanoparticle to form T cell–targeted particles. By conjugating multiple activating ligands, T cell transfection and stimulation in vitro was increased, and greater T cell transfection and selectivity in vivo was achieved compared to an untargeted particle. These nanoparticles can flexibly encapsulate mRNA cargos and were used to deliver anti-CD19 CAR mRNA in vivo, enabling depletion of 95% of B cells in the peripheral blood and 50% depletion of splenic B cells in healthy mice. These findings regarding nanoparticle tropism and their potential therapeutic efficacy highlight the importance of this nonviral, polymeric platform to address key limitations associated with current CAR T practices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
- Institute for NanoBioTechnology, and Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
- Johns Hopkins Translational ImmunoEngineering Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
- Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.
- Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
- Center for Autoimmunity and Immuno-Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
ORCID-Profile: Manav Jain, Savannah E Est-Witte, Sydney R Shannon, Sarah Y Neshat, Xinjie Yu, Leonardo Cheng, Stephany Y Tzeng, Jonathan P Schneck, Jordan J Green
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- NIDDK NIH HHS
- NIBIB NIH HHS
- National Institutes of Health
- National Science Foundation Graduate Research Fellowship
Zitieren
APA
Jain, M., Est-Witte, S. E., Shannon, S. R., Neshat, S. Y., Yu, X., Dunham, S., Tian, T., Cheng, L., Harris, J., Konig, M. F., Tzeng, S. Y., Schneck, J. P., & Green, J. J. (2026). Biodegradable targeted polymeric mRNA nanoparticles enable in vivo CD19 CAR T cell generation and lead to B cell depletion. Science Advances. https://doi.org/10.1126/sciadv.adz1722
Vancouver
Jain M, Est-Witte SE, Shannon SR, Neshat SY, Yu X, Dunham S, et al. Biodegradable targeted polymeric mRNA nanoparticles enable in vivo CD19 CAR T cell generation and lead to B cell depletion. Science Advances. 2026. doi:10.1126/sciadv.adz1722
BibTeX
@article{Jain2026,
author = {Jain, Manav and Est-Witte, Savannah E and Shannon, Sydney R and Neshat, Sarah Y and Yu, Xinjie and Dunham, Sydney and Tian, Tina and Cheng, Leonardo and Harris, Jawaun and Konig, Maximilian F and Tzeng, Stephany Y and Schneck, Jonathan P and Green, Jordan J},
title = {Biodegradable targeted polymeric mRNA nanoparticles enable in vivo CD19 CAR T cell generation and lead to B cell depletion},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.adz1722}
}
EUVIMED